Deceptively benign low-grade fibromyxoid sarcoma: Array-comparative genomic hybridization decodes the diagnosis

Jamie L. Odem, Gabor Oroszi, Kristen Bernreuter, Vasiliki Grammatopoulou, Scott R. Lauer, David D. Greenberg, Carole A. Vogler, Jacqueline R. Batanian

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Low-grade fibromyxoid sarcoma (previously known as Evans tumor) is a rare soft tissue neoplasm characterized by a deceptively bland appearance despite the potential for late metastasis or recurrence. We describe a 13-year-old patient with a popliteal fossa mass initially thought to be benign that, because of array-comparative genomic hybridization findings and subsequent immunohistochemistry, was diagnosed as low-grade fibromyxoid sarcoma. The array-comparative genomic hybridization demonstrated a loss of 11p11.2p15.5 and a gain of 16p11.2p13.3 with breakpoints involving the CREB3L1 (cAMP responsive element-binding protein 3-like 1) and FUS (fused in sarcoma) genes, respectively. Subsequent fluorescence in situ hybridization analysis of a dual-labeled break-apart FUS probe on interphase cells was positive. Our case highlights the importance of using genetic information obtained via array-comparative genomic hybridization to classify accurately pediatric soft tissue tumors.

Original languageEnglish (US)
Pages (from-to)145-150
Number of pages6
JournalHuman Pathology
Volume44
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Comparative Genomic Hybridization
Sarcoma
Soft Tissue Neoplasms
Interphase
Fluorescence In Situ Hybridization
Neoplasms
Carrier Proteins
Immunohistochemistry
Pediatrics
Neoplasm Metastasis
Recurrence
Genes

Keywords

  • Array-comparative genomic hybridization
  • CREB3L1 gene
  • Fused in sarcoma (FUS) gene
  • Low-grade fibromyxoid sarcoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Odem, J. L., Oroszi, G., Bernreuter, K., Grammatopoulou, V., Lauer, S. R., Greenberg, D. D., ... Batanian, J. R. (2013). Deceptively benign low-grade fibromyxoid sarcoma: Array-comparative genomic hybridization decodes the diagnosis. Human Pathology, 44(1), 145-150. https://doi.org/10.1016/j.humpath.2012.07.021

Deceptively benign low-grade fibromyxoid sarcoma : Array-comparative genomic hybridization decodes the diagnosis. / Odem, Jamie L.; Oroszi, Gabor; Bernreuter, Kristen; Grammatopoulou, Vasiliki; Lauer, Scott R.; Greenberg, David D.; Vogler, Carole A.; Batanian, Jacqueline R.

In: Human Pathology, Vol. 44, No. 1, 01.01.2013, p. 145-150.

Research output: Contribution to journalArticle

Odem, JL, Oroszi, G, Bernreuter, K, Grammatopoulou, V, Lauer, SR, Greenberg, DD, Vogler, CA & Batanian, JR 2013, 'Deceptively benign low-grade fibromyxoid sarcoma: Array-comparative genomic hybridization decodes the diagnosis', Human Pathology, vol. 44, no. 1, pp. 145-150. https://doi.org/10.1016/j.humpath.2012.07.021
Odem, Jamie L. ; Oroszi, Gabor ; Bernreuter, Kristen ; Grammatopoulou, Vasiliki ; Lauer, Scott R. ; Greenberg, David D. ; Vogler, Carole A. ; Batanian, Jacqueline R. / Deceptively benign low-grade fibromyxoid sarcoma : Array-comparative genomic hybridization decodes the diagnosis. In: Human Pathology. 2013 ; Vol. 44, No. 1. pp. 145-150.
@article{c50030f3ea514213a7a3bafc4a0cea45,
title = "Deceptively benign low-grade fibromyxoid sarcoma: Array-comparative genomic hybridization decodes the diagnosis",
abstract = "Low-grade fibromyxoid sarcoma (previously known as Evans tumor) is a rare soft tissue neoplasm characterized by a deceptively bland appearance despite the potential for late metastasis or recurrence. We describe a 13-year-old patient with a popliteal fossa mass initially thought to be benign that, because of array-comparative genomic hybridization findings and subsequent immunohistochemistry, was diagnosed as low-grade fibromyxoid sarcoma. The array-comparative genomic hybridization demonstrated a loss of 11p11.2p15.5 and a gain of 16p11.2p13.3 with breakpoints involving the CREB3L1 (cAMP responsive element-binding protein 3-like 1) and FUS (fused in sarcoma) genes, respectively. Subsequent fluorescence in situ hybridization analysis of a dual-labeled break-apart FUS probe on interphase cells was positive. Our case highlights the importance of using genetic information obtained via array-comparative genomic hybridization to classify accurately pediatric soft tissue tumors.",
keywords = "Array-comparative genomic hybridization, CREB3L1 gene, Fused in sarcoma (FUS) gene, Low-grade fibromyxoid sarcoma",
author = "Odem, {Jamie L.} and Gabor Oroszi and Kristen Bernreuter and Vasiliki Grammatopoulou and Lauer, {Scott R.} and Greenberg, {David D.} and Vogler, {Carole A.} and Batanian, {Jacqueline R.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.humpath.2012.07.021",
language = "English (US)",
volume = "44",
pages = "145--150",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Deceptively benign low-grade fibromyxoid sarcoma

T2 - Array-comparative genomic hybridization decodes the diagnosis

AU - Odem, Jamie L.

AU - Oroszi, Gabor

AU - Bernreuter, Kristen

AU - Grammatopoulou, Vasiliki

AU - Lauer, Scott R.

AU - Greenberg, David D.

AU - Vogler, Carole A.

AU - Batanian, Jacqueline R.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Low-grade fibromyxoid sarcoma (previously known as Evans tumor) is a rare soft tissue neoplasm characterized by a deceptively bland appearance despite the potential for late metastasis or recurrence. We describe a 13-year-old patient with a popliteal fossa mass initially thought to be benign that, because of array-comparative genomic hybridization findings and subsequent immunohistochemistry, was diagnosed as low-grade fibromyxoid sarcoma. The array-comparative genomic hybridization demonstrated a loss of 11p11.2p15.5 and a gain of 16p11.2p13.3 with breakpoints involving the CREB3L1 (cAMP responsive element-binding protein 3-like 1) and FUS (fused in sarcoma) genes, respectively. Subsequent fluorescence in situ hybridization analysis of a dual-labeled break-apart FUS probe on interphase cells was positive. Our case highlights the importance of using genetic information obtained via array-comparative genomic hybridization to classify accurately pediatric soft tissue tumors.

AB - Low-grade fibromyxoid sarcoma (previously known as Evans tumor) is a rare soft tissue neoplasm characterized by a deceptively bland appearance despite the potential for late metastasis or recurrence. We describe a 13-year-old patient with a popliteal fossa mass initially thought to be benign that, because of array-comparative genomic hybridization findings and subsequent immunohistochemistry, was diagnosed as low-grade fibromyxoid sarcoma. The array-comparative genomic hybridization demonstrated a loss of 11p11.2p15.5 and a gain of 16p11.2p13.3 with breakpoints involving the CREB3L1 (cAMP responsive element-binding protein 3-like 1) and FUS (fused in sarcoma) genes, respectively. Subsequent fluorescence in situ hybridization analysis of a dual-labeled break-apart FUS probe on interphase cells was positive. Our case highlights the importance of using genetic information obtained via array-comparative genomic hybridization to classify accurately pediatric soft tissue tumors.

KW - Array-comparative genomic hybridization

KW - CREB3L1 gene

KW - Fused in sarcoma (FUS) gene

KW - Low-grade fibromyxoid sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84870690814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870690814&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2012.07.021

DO - 10.1016/j.humpath.2012.07.021

M3 - Article

C2 - 23089491

AN - SCOPUS:84870690814

VL - 44

SP - 145

EP - 150

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 1

ER -